191 related articles for article (PubMed ID: 16629859)
1. 5-HT receptors and visceral hypersensitivity - 2B or not 2B, that is the question?
Grundy D
Neurogastroenterol Motil; 2006 May; 18(5):339-42. PubMed ID: 16629859
[No Abstract] [Full Text] [Related]
2. 5-HT4 receptor agonists: similar but not the same.
De Maeyer JH; Lefebvre RA; Schuurkes JA
Neurogastroenterol Motil; 2008 Feb; 20(2):99-112. PubMed ID: 18199093
[TBL] [Abstract][Full Text] [Related]
3. Translating 5-HT receptor pharmacology.
Sanger GJ
Neurogastroenterol Motil; 2009 Dec; 21(12):1235-8. PubMed ID: 19906028
[TBL] [Abstract][Full Text] [Related]
4. Wood creosote prevents CRF-induced motility via 5-HT3 receptors in proximal and 5-HT4 receptors in distal colon in rats.
Ataka K; Kuge T; Fujino K; Takahashi T; Fujimiya M
Auton Neurosci; 2007 May; 133(2):136-45. PubMed ID: 17182287
[TBL] [Abstract][Full Text] [Related]
5. Ion channels as targets for treatment of gastrointestinal motility disorders.
Farrugia G
Eur Rev Med Pharmacol Sci; 2008 Aug; 12 Suppl 1():135. PubMed ID: 18924455
[No Abstract] [Full Text] [Related]
6. Azaadamantane benzamide 5-HT4 agonists: gastrointestinal prokinetic SC-54750.
Becker DP; Flynn DL; Shone RL; Gullikson G
Bioorg Med Chem Lett; 2004 Nov; 14(22):5509-12. PubMed ID: 15482914
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and in vitro effects of tegaserod, a serotonin 5-hydroxytryptamine 4 (5-HT4) receptor agonist with prokinetic activity in horses.
Delco ML; Nieto JE; Craigmill AL; Stanley SD; Snyder JR
Vet Ther; 2007; 8(1):77-87. PubMed ID: 17447227
[TBL] [Abstract][Full Text] [Related]
8. Desperately seeking serotonin... A commentary on the withdrawal of tegaserod and the state of drug development for functional and motility disorders.
Pasricha PJ
Gastroenterology; 2007 Jun; 132(7):2287-90. PubMed ID: 17570201
[No Abstract] [Full Text] [Related]
9. Serotonin and the GI tract.
Hasler WL
Curr Gastroenterol Rep; 2009 Oct; 11(5):383-91. PubMed ID: 19765366
[TBL] [Abstract][Full Text] [Related]
10. Development of drugs for gastrointestinal motor disorders: translating science to clinical need.
Sanger GJ; Alpers DH
Neurogastroenterol Motil; 2008 Mar; 20(3):177-84. PubMed ID: 18257767
[TBL] [Abstract][Full Text] [Related]
11. Pharmacology of the new treatments for lower gastrointestinal motility disorders and irritable bowel syndrome.
Camilleri M
Clin Pharmacol Ther; 2012 Jan; 91(1):44-59. PubMed ID: 22071696
[No Abstract] [Full Text] [Related]
12. Upper gastrointestinal promotility drugs: not all uniform?
Brun R; Kuo B
Indian J Gastroenterol; 2009; 28(4):123-5. PubMed ID: 19937420
[No Abstract] [Full Text] [Related]
13. Electro-acupuncture attenuates stress-induced defecation in rats with chronic visceral hypersensitivity via serotonergic pathway.
Tian XY; Bian ZX; Hu XG; Zhang XJ; Liu L; Zhang H
Brain Res; 2006 May; 1088(1):101-8. PubMed ID: 16650387
[TBL] [Abstract][Full Text] [Related]
14. Serotonin: a review.
Mohammad-Zadeh LF; Moses L; Gwaltney-Brant SM
J Vet Pharmacol Ther; 2008 Jun; 31(3):187-99. PubMed ID: 18471139
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo pharmacological characterization of PF-01354082, a novel partial agonist selective for the 5-HT(4) receptor.
Mikami T; Komada T; Sugimoto H; Suzuki K; Ohmi T; Kimura N; Naganeo R; Nakata E; Nakatani K; Toga T; Eda H; Sakakibara M
Eur J Pharmacol; 2009 May; 609(1-3):5-12. PubMed ID: 19285067
[TBL] [Abstract][Full Text] [Related]
16. [Serotoninergic nervous system: gradients of neural influences in the norm and pathology].
Lychkova AE
Eksp Klin Gastroenterol; 2003; (6):114-20. PubMed ID: 15065540
[No Abstract] [Full Text] [Related]
17. [Gastrointestinal motility disorders and drugs: opioids, calcium antagonists, nitrates, peptides, prostaglandins and 5-hydroxytryptaminergic drugs (part II)].
Jovanović-Mićić D; Samardzić R; Beleslin B
Srp Arh Celok Lek; 1994; 122(3-4):88-92. PubMed ID: 17972818
[TBL] [Abstract][Full Text] [Related]
18. Serotonergic and non-serotonergic targets in the pharmacotherapy of visceral hypersensitivity.
Bueno L; de Ponti F; Fried M; Kullak-Ublick GA; Kwiatek MA; Pohl D; Quigley EM; Tack J; Talley NJ
Neurogastroenterol Motil; 2007 Jan; 19(1 Suppl):89-119. PubMed ID: 17280587
[TBL] [Abstract][Full Text] [Related]
19. [Prokinetic drugs in gastroenterology].
Galmiche JP; Bruley des Varannes S; Le Bodic L
Gastroenterol Clin Biol; 1991; 15(2 ( Pt 3)):T7-10. PubMed ID: 2065903
[No Abstract] [Full Text] [Related]
20. Drugs affecting visceral sensitivity: ready for the prime time?
Delvaux MM; Gay G
Dig Dis; 2006; 24(1-2):99-104. PubMed ID: 16699268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
